COVID-19 vaccines provide better protection against related pneumonia than previous symptomatic infection
Objectives: To compare, in a real-world scenario, the protective effect of vaccination and previous laboratory-confirmed symptomatic infection on the risk of COVID-19 pneumonia. Methods: A retrospective study was conducted and 46,998 adults with laboratory-confirmed COVID-19 were enrolled. Risk rati...
Main Authors: | Efrén Murillo-Zamora, Xóchitl Trujillo, Miguel Huerta, Mónica Ríos-Silva, José Guzmán-Esquivel, Verónica Benites-Godínez, María Regina Ochoa-Castro, José Alejandro Guzmán-Solórzano, Oliver Mendoza-Cano |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971222002454 |
Similar Items
-
Effectiveness of BNT162b2 COVID-19 Vaccine in Preventing Severe Symptomatic Infection among Healthcare Workers
by: Efrén Murillo-Zamora, et al.
Published: (2021-07-01) -
Performance of Antigen-Based Testing as Frontline Diagnosis of Symptomatic COVID-19
by: Efrén Murillo-Zamora, et al.
Published: (2021-08-01) -
Predictors of Recurrent Laboratory-Confirmed Symptomatic SARS-CoV-2 Infections in a Cohort of Healthcare Workers
by: Xóchitl Trujillo, et al.
Published: (2023-03-01) -
Reemerging Influenza Virus Infections during the Dominance of the Omicron SARS-CoV-2 Variant in Mexico
by: Mónica Ríos-Silva, et al.
Published: (2022-10-01) -
COVID-19 Pneumonia in Fully Vaccinated Adults during the Dominance of the Omicron Sublineages BA.1.1 and BA.2 in Mexico
by: Efrén Murillo-Zamora, et al.
Published: (2022-08-01)